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Activating mutations in the KRAS oncogene are associated with three related human syndromes, which vary
in hair and skin phenotypes depending on the involved allele. How variations in RAS signals are interpreted
during hair and skin development is unknown. In this study, we investigated the developmental and
transcriptional response of skin and hair to changes in RAS activity, using mouse genetic models and
microarray analysis. While activation of Kras (KrasG12D) in the skin had strong effects on hair growth and hair
shape, steady state changes in downstream RAS/MAPK effectors were subtle and detected only by
transcriptional responses. To model the transcriptional response of multiple developmental pathways to
active RAS, the effects of growth factor stimulation were studied in skin explants. Here FGF acutely
suppressed Shh transcription within 90 min but had signiﬁcantly less effect on Eda, WNT, Notch or BMP
pathways. Furthermore, in vivo Fgfr2 loss-of-function in the ectoderm caused derepression of Shh, revealing a
role for FGF in Shh regulation in the hair follicle. These studies deﬁne both dosage sensitive effects of RAS
signaling on hair morphogenesis and reveal acute mechanisms for ﬁne-tuning Shh levels in the hair follicle.
& 2012 Elsevier Inc. All rights reserved.Introduction
RAS is a common downstream component of multiple signaling
pathways, which include receptor tyrosine kinases (RTKS), asso-
ciated growth factors, cytokines, integrin cross-linking, G-protein
coupled receptors activation, and other stimuli (Reuther and Der,
2000). In its active state, RAS stimulates several parallel effector
pathways, and depending on the experimental setting, a variety of
cellular responses may ensue including migration, proliferation,
survival, differentiation, and senescence (Malumbres and Barbacid,
2003; Rodriguez-Viciana et al., 1997). In the setting of cancer,
mutations in RAS maintain RAS in its activated state and drive
persistent proliferation and survival of transformed cells via one or
more effector pathways. As a central mediator of multiple signaling
pathways, pharmacologic inhibition of RAS, its post-translational
modiﬁcation, or its downstream effector proteins has been widely
pursued as a potential treatment for cancer (Bollag et al., 2010;
Downward, 2003; Rodriguez-Viciana et al., 2005). Mutations in RAS
paralogs are also found in a growing number of genetic disorders,
including Costello, Cardiofaciocutaneous and Noonan syndromes
(Rauen et al., 2010; Tidyman and Rauen, 2009). Collectively, these
syndromes, termed RAS/MAPK syndromes or RASopathies, manifestll rights reserved.in patients with several developmental abnormalities including
craniofacial, cardiac, neural, cognitive and ectodermal defects.
Cardiac defects include valvular malformations, cardiac hypertro-
phy, and arrhythmias (Lin et al., 2011), and in the nervous system,
patients are affected by delayed development, cerebellar enlarge-
ment and cognitive defects (Axelrad et al., 2009; Gripp et al., 2010).
In the integument, epidermal, hair, and nail defects are more
divergent among RAS/MAPK syndromes. In Costello syndrome,
redundant skin, papillomas, and palmar defects are highly charac-
teristic, while sparse hair and perifollicular changes are common
and characteristic in CFC patients (Siegel et al., 2012). Other
phenotypes, including curly hair and heat intolerance, are common
to both CFC and Costello syndrome. Differences in skin phenotypes
provide important criteria for delineating between the three distinct
syndromic forms (Siegel et al., 2011). Cutaneous phenotypes among
RAS/MAPK syndromes suggest that different RAS paralogs, alleles and
effectors are capable of inducing distinct developmental responses.
In Costello syndrome (CS), patients (495%) carry activating HRAS
mutations (Aoki et al., 2005); CFC patients (60%) show predomi-
nantly BRAF, MEK1, or MEK2 mutations (Rodriguez-Viciana et al.,
2006); 50% of Noonan syndrome patients carry PTPN11 loss-of-
function mutations (Noonan, 2006). Uncommonly, mutations in the
paralog Kras occur in RAS/MAPK syndromes. Mutations of this
paralog have been reported in all three syndromes, including
KRAS[K5E/K5N/F156L] in CS (Bertola et al., 2007; Zenker et al.,
A. Mukhopadhyay et al. / Developmental Biology 373 (2013) 373–3823742007) and KRAS[P34R/V14I/T58I/D153V] in CFC/Noonan (Schubbert
et al., 2006). The pleiotropic effects of KRAS mutations indicate that
that paralog differences alone may not be sufﬁcient to explain the
phenotypic spectrum of RAS/MAPK syndromes. Moreover, in mouse
models, when KrasG12D is activated in the skin, KRAS causes redun-
dant skin, hair loss and papillomas, which are characteristics features
of HRAS-associated Costello syndrome in humans (Mukhopadhyay
et al., 2011). These studies suggest that phenotypic variation in the
skin may be caused by both allelic differences and paralog differences
in RAS/MAPK syndromes. Differential cellular responses to RTK signal
strength has been implicated as a mechanism to specify multiple cell
fates and developmental responses using a single signaling pathway
(Schweitzer and Shilo, 1997). In experimental models, amplitude and
duration of RTK activation contribute to differential cellular and
discrete transcriptional responses (Marshall, 1995; Murphy et al.,
2002). The spectrum of phenotypes that differentiate RAS/MAPK
syndromes suggest developmental dose-sensitive RTK responses
may also exist in the hair and skin of humans and other mammals.
To identify developmental and signaling mechanisms that sense
changes in RAS activity, we sought to identify RAS-responsive
molecular and developmental pathways in the skin using a KrasG12D
gain-of-function model. In this model, KrasG12D allele induced a curly
hair phenotype, altered hair shaft features important for the produc-
tion of hair subtypes, and altered the transcriptional program of
several developmental pathways of the hair follicle. To identify
developmental pathways that are sensitive to RAS signal strength,
the transcriptional response of skin explants was examined in
response to varying doses of growth factors and inhibitors of the
RAS signaling pathway. This approach revealed that growth factor
stimulation acutely downregulates Shh in the hair follicle. These
studies provide evidence for the sensitivity of developmental path-
ways of the skin in response to RAS signal variation.Materials and methods
Mice and animal care
Mice have been generated and genotyped as previously described
for Krastm4Tyj/J (Tuveson et al., 2004) and Fgfr2ﬂox/ﬂox alleles (Yu et al.,
2003). Lines have beenmaintained in mixed genetic backgrounds. All
experiments were performed according to the institutional guide-
lines established by the University of California, San Diego, Institu-
tional Animal Care and Use Committees.
Analysis of hair, hair length, and hair shaft structures
Hair shafts were plucked from three P14 and three P47 animals
from each genotype: wildtype and Msx2-cre; KrasG12D mice. The
numbers of bends and medullar spaces were tabulated as indepen-
dent features. Statistical analysis was performed with Prizm 5 (Graph-
Pad Software). Hair length was determined using Image (Wayne
Rasband, NIH) and the distributions of hair lengths were compared
using the Kendall-Sherman test. For analysis of hair growth from P4
to P7, ﬁxed skin was dehydrated in ethanol and cleared in methyl
salicylate. Thick sections (2–3 hair follicles wide) were cut, imaged,
and analyzed by NeuronJ (Meijering et al., 2004). Cuticle casts were
generated from imprints of hair shafts, embedded in Permount and
air-dried overnight at room temperature.
Protein phosphorylation analysis
Dorsal skin from postnatal (P) day 7 wildtype and Msx2-cre;
KrasG12D mice was collected, minced, frozen, and pulverized in
liquid nitrogen. Protein was isolated in lysis buffer containing
50 mM Tris–HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.25% sodiumdeoxycholate, 1 mM EDTA, 5 mM NaF, 2 mM sodium vanadate,
and 1 Complete protease inhibitor (Roche). Antibodies used in
Western blotting are listed in Supplementary methods. Western
analysis was performed with goat anti-mouse IgG (IRDye 800CW,
Li-COR, USA) and goat anti-rabbit IgG (IRDye 680CW, Li-COR,
USA), visualized using an Odyssey Infrared Imager (Li-COR, USA).
Gene expression analyses, real-time PCR and microarray studies
Dorsal skin where Msx2-cre is most active was used for RNA
studies. Whole skin was minced, transferred into TRIzol (Life
Technologies Corp.), and homogenized by mechanical bead dis-
ruption (BioSpec Products). Total RNA was isolated according to
manufacturer’s protocol. Quantitative RT-PCR was performed
using Maxima qPCR reagents (Fermentas Inc.) and a LightCycler
480 (Roche). Taqman reagents and primers for SYBR reactions are
listed in Supplementary methods. Relative mRNA levels were
normalized to beta-actin and expressed using a baseline-
independent method was used to determine the fractional cycle
number and the cycle number was used to calculate the amount
of each product using the delta CP calculations. Levels of PCR
product were expressed as a function of beta-actin . Microarray
analysis was performed in triplicate from total RNA of control and
Msx2-cre; KrasG12D P7 mice by the UCSD BIOGEM Microarray core
for quality control, reverse transcription, labeling, and hybridiza-
tion to Mouse WG-6 V2 Beadchips (Illumina, Inc.). Differential
gene expression P-values were calculated from multiple hypoth-
esis correction (Yekutieli and Benjamini, 2001). For comparison of
microarray data to hair follicle lineages, we used the standards
described in GEO Dataset GDS1323 (Rendl et al., 2005) to
determine cell-type speciﬁc genes, as deﬁned by Z2-fold in one
cell population as compared to all others. Additional statistical
methods are detailed in Supplemental methods. Wildtype and
Msx2-cre; KrasG12D mouse skin microarray data can be accessed
at the ArrayExpress database, accession: E-MTAB-700 .
Histology, in situ hybridization, and immunoﬂuorescence staining
Histology was performed as previously described (Mukhopadhyay
et al., 2011). In situ hybridization was performed as previously
described (Etchevers et al., 2001). Anti-sense digoxygenin riboprobes
were generated, according to manufacturer’s instructions (Roche).
K17 riboprobe was generated from a PCR template using forward
(50-TGGCAGTGGTTATGGAGGCAAC-30) and reverse primers (50-CCAG-
CAATCCTACCTTGTTCTTCAG-30) containing T7 promoter. Shh ribop-
robe was previously described (Lewis et al., 2001). Image capture was
performed with a DP71 (Olympus) camera mounted on a BX51
stereomicroscope (Olympus). Immunoﬂuorescence staining was per-
formed on paraformaldehyde-ﬁxed tissue in conjunction with citrate
antigen retrieval. Primary antibodies used were: phospho-H3 (Ser10)
(1:250, Cell Signaling), AE15 (1:500, Santa Cruz Biotechnologies),
AE13 (1:500, Santa Cruz Biotechnologies). For cell counts, positive
phospho-H3 and Shh staining in hair follicles were counted from at
least three mice and subjected to a Mann-Whitney statistical test
from Prism 5 (GraphPad Software, Inc.).
Skin explant culture and analysis
Wildtype 1.5 mm punch biopsies were obtained from the
dorsal skin of euthanized CF1 outbred and C576Bl/6 inbred P7
animals and placed in DMEM supplemented with 10% fetal calf
serum (Mediatech, Inc.) and antibiotics. Growth factors and their
sources are provided on Supplemental methods. Explants were
treated with vehicle, media and serum for 90 min were used as
controls. RNA was extracted from biopsies as above and analyzed
by quantitative RT-PCR .
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RAS gain-of-function alters hair shape and size
In order to activate KrasG12D from its endogenous locus, we
utilized a loxP permissive allele, LSL-KrasG12D, in which a loxP-STOP-
loxP (LSL) cassette prevents gene expression until excised by Cre
recombinase. To perform Cre-loxP recombination in the hair follicle,
we bred LSL-KrasG12D mouse to theMsx2-cre transgenic line, which is
active in the matrix of the postnatal hair follicle and in the dorsal skin
during embryonic development (Pan et al., 2004; Sun et al., 2000). In
other embryonic tissues,Msx2-cre is expressed in the apical ectoderm
ridge of the early limb bud. Offspring carrying both Msx2-cre andFig. 1. Hair analysis of wildtype and Msx2-cre; KrasG12D gain-of-function mice. (A) (L
panels) darkﬁeld micrographs of hair shaft morphology. Wildtype mice demonstrate ch
KrasG12D-hair shafts were short, curved and lacked hair bends. Scale bar¼1 mm. (B) Fre
columns (right panel) in wildtype and KrasG12D mice. Tracing of representative hair shaft
medulla columns. Single asterisk (*), P¼0.003; double asterisks (**), P¼0.009. (C) Freq
4100 hair shafts from at least three animals of each genotype with a mean hair lengtLSL-KrasG12D (hereafter referred to Msx2-cre; KrasG12D) were viable
and lacked obvious external changes, e.g., normal limbs and facies.
Thus, Msx2-cre overcomes the neonatal lethality associated with
previously reported activation of KrasG12D by keratinocyte-speciﬁc
Keratin 14 (K14)-cre (Tuveson et al., 2004). Hair growth in Msx2-cre;
KrasG12D became visibly abnormal by 1–2 weeks (Fig. 1A). Mice
produce four different hair types, guard, awl, auchene and zigzags,
which can be identiﬁed based on differences in their length, relative
frequency, number of constrictions (bends), and internal columns
(medulla) (Mustonen et al., 2003; Sundberg, 1994). Microscopic
analysis of Msx2-cre; KrasG12D hair revealed multiple abnormalities
in hair shaft formation (Fig. 1B). Hair bends were absent inMsx2-cre;
KrasG12D mice. In addition, the number of medulla per hair (P¼0.004;eft panels) P14 wildtype (wt) and Msx2-cre; KrasG12D (KrasG12D) mice and (right
aracteristic guard (gh), intermediate awl/auchene (int), and zigzag (zz) hair types.
quency of hair with hair bends (left panel) and with varying numbers of medulla
at low power demonstrating four bends and, at higher power, demonstrating three
uency of hair of varying lengths in wildtype and KrasG12D mice. Data represents
h of 5.98 and 4.11 mm in wildtype and KrasG12D mice, respectively (Po0.0001).
Fig. 3. Appearance, proliferation, differentiation of Msx2-cre; KrasG12D hair
follicles. (A) Placode morphology and density (inset) at E15.5 revealed by keratin
17 (K17) RNA in situ hybridization in wildtype and Msx2-cre; KrasG12D (KrasG12D)
embryos. Sections are counterstained with Sytox Green. Scale bar¼200 mm.
((B) and (C)) Histology of P0 and P5 hair follicles demonstrating similar hair
G12D G12D
A. Mukhopadhyay et al. / Developmental Biology 373 (2013) 373–382376ANOVA) and length (P¼1.71012; ANOVA) were reduced inMsx2-
cre; KrasG12D mice (Fig. 1C). To characterize the short hair phenotype,
we examined hair length at P4 and P7 of cleared whole skin (Fig. 2A).
Image tracings of hair fromwildtype skin demonstrated an average of
1.81 mm growth over the three-day period, while Msx2-cre; KrasG12D
littermates grew only 0.82 mm within the same interval (Fig. 2B–D ).
These ﬁndings indicate that the reduced hair length of Msx2-cre;
KrasG12D mice is caused by slower hair growth. To investigate other
possible causes of short hair, we examined the timing of hair
development in Msx2-cre; KrasG12D mice. The earliest hair follicles
of the dorsal skin initiate development at embryonic (E) day 14.5 and
are responsible for the production of the longest hairs (guard hairs).
We assessed that presence of hair follicles at E15.5 by the expression
of keratin 17 (K17) and found that placode maturation and density
was normal in Msx2-cre; KrasG12D embryos (Fig. 3A). At neonatal and
early postnatal stages, when all hair types are present, hair follicles
were identiﬁed at normal density and maturation (Fig. 3B and C;
Supplementary materials Fig. S2). In addition, differentiation into hair
shaft lineages, medulla, cortex and cuticle, was readily detected
(Fig. 3D and E). Further analysis of the external morphology of
Msx2-cre; KrasG12D hair shafts showed normal cuticle morphology
(Supplementary materials Fig. S2). To investigate the reduced hair
production ofMsx2-cre; KrasG12Dmice, proliferation of the hair matrix
was examined (Fig. 3F and G). The number of phospho-histone
H3-positive cells in the hair follicle bulb region, a molecular change
equivalent to mitotic index, was signiﬁcantly reduced in Msx2-cre;
KrasG12D mice (P¼0.03). These ﬁndings indicate the activated RAS
does not speciﬁcally block hair differentiation but alters the rate of
hair growth.follicle density and maturation in wildtype and Kras mice. At P5, Kras hair
follicles begin to demonstrate abnormal orientation. Scale bars¼500 mm. ((D) and
(E)) Immunoﬂuorescent analysis of hair differentiation in wildtype and KrasG12D
P7 hair follicles. Hair keratin (AE13)-positive staining delineates hair cortical and
cuticle cells, which are present in both wildtype and KrasG12D mutant skin.
Trichohyalin (AE15)-positive staining reveals internal hair medulla cells in addi-
tion to supporting IRS cells. Scale¼20 mm. (F, G) Mitotic index determined by
phospho-histone H3 (ph-H3) staining on P7 wildtype and KrasG12D mutant hair
follicles. Numbers of ph-H3-positive cells per hair bulb were determined for both
genotypes. Scale¼20 mm. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)Cutaneous activation of RAS induces genes associated
with the RTK-signaling pathway
The KrasG12D allele, while acting as a gain-of-function, has been
shown to be hyperactive rather than persistent and constitutive
in other models (Tuveson et al., 2004). To determine if the steady-
state level of RAS activation was normal in the skin of Msx2-cre;
KrasG12D mice, we examined the overall activity of the RAS/MAPKFig. 2. Growth of hair follicles in wildtype and Msx2-cre; KrasG12D mice.
(A) Cleared P4 whole skin of wildtype and Msx2-cre; KrasG12D mice, demonstrating
hair shaft and hair follicles. (B) Tracings of example complete hair shaft and
follicles from cleared P4 skin. Asterisks indicate broken hair shafts, which were
excluded from analysis. Scale bar¼100 mm. (C) Plot of average length of P4 vs. P7
hair shafts from wildtype and Msx2-cre; KrasG12D mice, representing at least four
mice per age. (D) Summary of change in hair length between P4 and P7 in
wildtype and Msx2-cre; KrasG12D mice and statistical signiﬁcance.pathway at P7 by a quantitative, non-enzymatic Western
approach (Fig. 4A and B). In addition, whole skin was utilized as
extensive dissection of tissue would likely lead to non-physiologic
activation of the RAS/MAPK pathway. Levels of phosphorylated
MEK, ERK and AKT were found to be normal in the Msx2-cre;
KrasG12D mice. Although KrasG12D is active and sufﬁcient to induce
phenotypic changes in the hair, epigenetic events such as the
upregulation of negative feedback networks may reset the steady
state levels of phosphorylated downstream proteins in vivo
(Courtois-Cox et al., 2006). Because multiple RAS/MAPK antago-
nists are transcriptionally-induced in response to growth factor
stimulation, their expression was used as a transcriptional
signature of elevated RAS/MAPK signaling (Kawakami et al.,
2003; Verheyden et al., 2005). Extensive dissection of hair follicles
and injury potentially activate RAS/MAPK ectopically (Corson
et al., 2003). To reduce the likelihood of ectopic activation, whole
skin of P7 animals was used as a source for RNA with the caveat
that some changes in hair follicle gene expression may be diluted
by surrounding tissue. Extracted RNA was subjected to micro-
array hybridization analysis, interrogating 45,281 unique,
expressed transcripts of 18,122 genes (Fig. 5). Microarray analysis
revealed 1891 signiﬁcantly altered genes (Z25% change from
wildtype, with Po0.05) and 144 genes altered by greater than 2-
fold (Fig. 5A). Affected genes in Msx2-cre; KrasG12D mice included
RAS/MAPK antagonists and other biomarkers of RAS/MAPK acti-
vation, e.g., Ets variant transcription factors, Etv1, and Etv4, Etv5,
Dusp6 and others (Fig. 5B). For several genes, real-time PCR was
A. Mukhopadhyay et al. / Developmental Biology 373 (2013) 373–382 377performed to conﬁrm the altered quantities of these transcripts
(Fig. 5C). These studies conﬁrmed that theMsx2-cre; KrasG12D skin
represents a heightened level of RAS/MAPK signaling and sug-
gested that in a developmental steady state, the developmental
and transcriptional response to RAS gain-of-function may be
more sensitive than biochemical changes.Fig. 4. Biochemical and transcriptional response of skin to KrasG12D. (A) Immunoblot
analysis of phosphorylated downstream effector proteins (green) in wildtype and
KrasG12D P4 skin. Samples show no signiﬁcant change after normalized with total ERK
(red), which also serves as a loading control. (B) Densitometry analysis of phos-
phorylated p90RSK, AKT, and ERK normalized to total ERK show no signiﬁcant change
of whole skin at baseline. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
Fig. 5. Microarray analysis of cutaneous response to KrasG12D. (A) Venn diagram of altere
expression and potential KrasG12D biomarkers from microarray analysis, 13,001 gene
signiﬁcantly altered between biological triplicates. (B) Effect of KrasG12D on the expressio
NS, not statistically signiﬁcant; ND, not detected. (C) Quantitative real-time PCR valida
Dusp6, Etv4, and Etv5. (D) Effect of KrasG12D on expression of hair matrix, ORS, and
expression is shown in gray. (E) Biological processes and P-values (negative log10
(For interpretation of the references to color in this ﬁgure legend, the reader is referreEffects of KrasG12D on hair proliferation and differentiation
RAS gain-of-function also had signiﬁcant effects on hair signaling
and gene expression. A comparison of KrasG12D-affected genes with
hair lineage gene expression (Rendl et al., 2005) revealed repression
of hair matrix lineage genes, including many involved with ecto-
dermal development and proliferation (Fig. 5D). In adjacent tissues,
genes expressed by the adjacent dermal papilla were not signiﬁ-
cantly altered and upregulated in the outer root sheath. Lineage
gene expression changes indicate that RAS has selective effects on
hair follicle lineages. The downregulation of matrix-speciﬁc genes
and positive regulators of proliferation led us to study the effect of
KrasG12D on lineage differentiation and cell proliferation of the hair
follicle (Fig. 5E).Interaction of KrasG12D with expression of hair signaling pathways
One of the goals of investigating RAS gain-of-function in the
hair and skin was to identify the dose-sensitive relationship
between growth factor signaling and developmental pathways.
The downregulation of hair matrix gene expression could reﬂect
one or more signaling pathways that are sensitive to RAS activa-
tion and that are known to participate in hair morphogenesis,
including Bone morphogenetic protein (BMP), Ectodysplasin
(EDA), FGF, Hedgehog (HH), WNT, and Notch (Fig. 6A)(Schneider
et al., 2009). Microarray analysis and real-time PCR of 19 genes
representative of transcriptional targets or critical ligands of six
pathways using microarray data and real-time PCR results sug-
gested a number of RAS-sensitive pathways (Fig. 6B and C).
However, whether these changes in Msx2-cre; KrasG12D mice
reﬂect secondary change to due the altered development of the
hair follicle could not be determined. To address these issues, wed gene expression (Po0.05) and table (4 change) summarizing differential gene
s noted in intersection of Venn diagram indicate number of genes that are not
n of previously reported biomarkers of RAS activation and growth factor signaling.
tion of RAS/growth factor signaling biomarkers conﬁrms increased expression of
dermal papilla (OP)-speciﬁc genes (red area curve). Normal distribution of gene
) of association reﬂected in gene expression as predicted by Gene Ontology.
d to the web version of this article.)
Fig. 6. Effect of KrasG12D on cutaneous expression of candidate morphogen path-
ways. (A) Legend for selected target genes tested and their association with
candidate morphogen pathways. (B) Microarray data for genes representing
morphogen pathways, demonstrating relative changes in gene expression in
KrasG12D/ wildtype. (C) Real-time PCR analysis of genes of morphogen pathways
of P7 whole skin from wildtype (solid) and KrasG12D (unﬁlled) mice.
Fig. 7. Effect of KrasG12D on cutaneous Hedgehog signaling. (A) Microarray analysis of
genes within the Hedgehog signaling pathway demonstrates decreased Shh in addition
to three downstream targets, Foxe1, Ptch1, and Ptch2. NS, no signiﬁcant change.
(B) Real-time PCR of analysis of Hedgehog pathway genes (Shh, Ptch1, Ptch2, Hhip1,
and Gli1 RNA) from P7 wildtype and KrasG12Dwhole skin (n¼4 of each genotype). (C) In
situ hybridization for Shh RNA in P7 wildtype and Msx2-cre; KrasG12D skin show similar
patterns of expression in hair follicle. (D) Western blot of SHH protein (green) and
ACTIN loading control (red) for four animals of each genotype. Summary of image
densitometry analysis indicates 25% reduction in SHH protein. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of
this article.)
A. Mukhopadhyay et al. / Developmental Biology 373 (2013) 373–382378utilized a skin explant assay to model physiologic RAS activation,
e.g., growth factor treatment, and to identify the acute transcrip-
tional response of the skin (Supplementary materials Fig. S3).
Among several candidate pathways, the level and statistical
signiﬁcance of Shh RNA modulation by FGF2 was most prominent.
Within 90 min of FGF2 stimulation, Shh RNA levels were reduced
up to 2.8-fold, P¼2105 (Supplementary materials Fig. S2). The
acute response in wildtype explants suggested that the relation-
ship between RTK signaling and Shh regulation may be direct.
Microarray data also corroborated the signiﬁcance of Shh changes
in vivo as several Hedgehog-related targets, including Shh, Ptch1,
Ptch2 and Foxe1 were also downregulated in Msx2-cre; KrasG12D
mice (Fig. 7A) (Brancaccio et al., 2004; Tabata and Kornberg,
1994). Conﬁrmation by quantitative real-time RT-PCR revealed a
3.78-fold reduction in Shh mRNA and a 2.17-fold reduction in its
target gene, Ptch1 in Msx2-cre; KrasG12D skin (Fig. 7B, Supplemen-
tary materials Fig. S4). The reduced expression of transcriptional
targets of the Hedgehog pathway indicated that in addition to
reduced ligand expression, activation of the Hedgehog pathway
was also reduced. To determine if reduced Shh levels affect the
expression pattern of Shh in the Msx2-cre; KrasG12D hair follicles,
in situ hybridization was performed (Fig. 7C). The domain of Shh
expression was essentially normal in Msx2-cre; KrasG12D hair
follicles but had reduced staining compared to wildtype hair
follicles. The reduction of Hedgehog target genes suggested the
reduction or inhibition of SHH ligand. Western analysis revealed
25% reduction of mature SHH protein (Fig. 7D). Thus, ex vivo
RTK stimulation and RAS gain-of-function in vivo repress cuta-
neous Shh levels.
Ex vivo effects of RAS inhibition and RTK stimulation
on Shh transcription
The above ﬁndings suggest that use of FGF in explant studies
recapitulate some aspects of Shh dysregulation in Msx2-cre;KrasG12D hair follicles. To further localize the response of Shh to
a component of RAS/MAPK signaling pathway, we examined the
effect of inhibition of RAS effector pathways. Treatment of
A. Mukhopadhyay et al. / Developmental Biology 373 (2013) 373–382 379explants with inhibitors against downstream components of
the RAS/MAPK pathway, c-RAF1 (GW5074; Lackey et al., 2000)
or MEK (U0126; Favata et al., 1998), caused an increase in Shh
mRNA levels (Fig. 8A). Treatment with a PI-3-kinase inhibitor
(LY294002; Vlahos et al., 1994) also resulted in increased Shh
mRNA levels. These studies provide further evidence that down-
stream effectors of RAS, i.e., MEK, RAF and PI-3-kinase, participate
in the regulation of Shh. We also reasoned that if Shh down-
regulation is RAS-mediated then the Shh response should be
broadly induced by multiple receptor tyrosine kinase (RTK)
signals. Thus, the response of Shh to epidermal growth factor
(EGF), platelet-derived growth factor (PDGF), and additional FGFs
(FGF7, FGF10) was also examined (Fig. 8B). Each growth factor
demonstrated a similar downregulation of Shh mRNA. Thus, in a
wildtype hair follicle, RTK activation or inhibition of RAS down-
stream effector pathways both elicit rapid changes in Shh levels.
The rapid loss of Shh mRNA in the presence of FGF2 could be
explained by a short intrinsic half-life of Shh mRNA or by
FGF-induced destabilization of Shh mRNA. Since the half-life ofFig. 8. Cutaneous Shh regulation in wildtype skin in response to growth factor
stimulation or RAS/MAPK inhibition. (A) Shh RNA explant levels following 90-min
inhibitor treatment with U0126 (MEK1/2), PD98059 (MEK1), GW5074 (c-RAF),
and LY294002 (PI-3-kinase). (B) Shh RNA explant levels in response to 90-min
treatment with EGF, PDGF, FGF2, FGF7 and FGF10. Explant results ((A) and (B))
reﬂect at least three control animal studies. (C) Similar kinetics of Shh RNA
downregulation in response to FGF2 or actinomycin (red dashed line) relative to
control treated skin explants. (D) Levels of Shh unspliced primary transcript are
reduced in the skin of Msx2-cre; KrasG12D mice relative to wildtype as detected by
proximal exon (þ70) and two downstream introns.Shh mRNA is unknown, we characterized the kinetics of Shh
mRNA loss after pharmacologic inhibition of global transcription
(Fig. 8C). Treatment of explants with actinomycin resulted in
rapid decay of ShhmRNA, revealing an intrinsically short half-life .
Furthermore, non-linear best-ﬁt modeling showed no signiﬁcant
change in the Shh RNA half-life of FGF2 vs. actinomycin-treated
explants (4.6 vs. 4.3 min, respectively, R240.98). These ﬁndings
suggest that FGF represses Shh mRNA levels by inhibiting tran-
scription. To determine if transcriptional repression is responsible
for decreased Shh mRNA in Msx2-cre; KrasG12D skin, the levels of
primary transcript of Shh RNA was evaluated (Fig. 8D). Since
primary transcripts are unspliced, primers against introns 1–2 , 2–
3 , and proximal regions of the ﬁrst exon of Shhwere generated to
detect the primary transcripts of Shh RNA. Like its mature Shh
mRNA, the primary transcripts of Shhwere decreased inMsx2-cre;
KrasG12D mice. These ﬁndings indicate that the ShhmRNA is short-
lived and transcriptionally repressed by growth factor signaling.
An endogenous RTK regulates Shh levels in vivo
The above studies suggested that RAS plays a role in Shh
regulation. However, because RAS activation responds to many
types of cellular signals, whether endogenous growth factor
ligands participate in Shh transcriptional regulation in the hair
follicle is unknown. In explant studies, we observed that several
growth factor ligands were capable of repressing Shh RNA levels.
FGF ligands play multiple roles in hair development, including
regulation of hair growth, length determination, and medulla
formation, and were ideal candidates for normal regulators of hair
follicle Shh levels (Schlake, 2007). FGF ligands bind to one of four
FGF receptors (FGFR) and activate their receptors in complex with
heparan sulfate proteoglycans (Yayon et al., 1991). All four FGFRs
are expressed in the hair follicle (Rosenquist and Martin, 1996).
Mouse knockout studies reveal that Fgfr3 and Fgfr4 are not
required for normal morphogenesis of the hair follicle (Deng
et al., 1996; Weinstein et al., 1998). Roles of Fgfr1 and Fgfr2 in
the hair follicle have been tested through tissue-speciﬁc inactiva-
tion and have demonstrated their roles in early formation of the
hair and later in the maintenance of the hair follicle unit (Grose
et al., 2007; Yang et al., 2010), but their role in ectodermal Shh
regulation is unknown. FGF7 and FGF10 selectively bind to
ectodermal isoforms of FGFR1 and FGFR2 and are sufﬁcient to
downregulate Shh levels in explants (cf. Fig. 8B). Speciﬁcally, we
wished to study the transcriptional response of Shh in the absence
of Fgfr2 in the same tissue domains as Msx2-cre; KrasG12D mice
(Fig. 9). Msx2-cre; Fgfr2ﬂox/ mice (Msx2-cre; Fgfr2cKO) were thus
generated. These mice displayed limb defects as previously
reported (Yu and Ornitz, 2008) but had normal skin and hair
until two weeks of age. After two weeks, the hair from Msx2-cre;
Fgfr2cKO mice became long, shiny and brittle, but the overall
density was normal (see below). Thus, in order to study the
response of Shh RNA to the loss of Fgfr2, we assayed Shh mRNA
levels at P7 prior to the onset of these abnormalities. We detected
Shh at more than 2-fold higher levels in Msx2-cre; Fgfr2cKO mice
relative to littermate controls, which included three genotypes,
Msx2-cre; Fgfr2ﬂox/þ , Fgfr2ﬂox/ , and Fgfr2ﬂox/þ (Fig. 9A, Supple-
mentary materials Fig S4 and not shown). Increased levels of Shh
mRNA were also accompanied by increased expression of
downstream genes, Ptch1, Ptch2, Hhip1, and Gli1, indicating that
Hedgehog signaling was increased in the Msx2-cre; Fgfr2cKO skin.
During normal hair follicle growth, Shh is expressed by a transient
migrating population of cells, which begins near the hair matrix.
As these cells move distally, they abruptly lose Shh expression and
eventually acquire an IRS or cuticle cell fate (Greco et al., 2009).
Ectopic or persistent expression of Shh might also result in
increased Shh levels in the whole skin of Msx2-cre; Fgfr2cKO mice.
Fig. 9. Genetic loss of Fgfr2 is associated with increased Shh gene expression. (A) Real-time PCR analysis of Hedgehog pathway gene expression (Shh, Ptch1, Ptch2, Hhip1
and G1i1) in wildtype and Msx2-cre; Fgfr2CKO (Fgfr2CKO) P7 mouse whole skin. (B) In situ hybridization of Shh RNA (purple) in wildtype and Fgfr2CKO mouse skin. Black
granules are melanin. (C) Average numbers of Shh-positive cells in hair bulb region of Fgfr2CKO, KrasG12D and wildtype littermates. At least three animals were used in these
studies and statistical differences between mutant and wildtype littermates were P¼0.4187 and P¼0.4355 for Fgfr2CKO and KrasG12D, respectively. (D) Relative resistance of
Shh downregulation by FGF2 in Fgfr2CKO P7 explants. Relative levels of Shh RNA are shown in Fgfr2CKO explants 790-min treatment with FGF2. (E) The schematic depicts
the pattern of Shh expression under normal conditions (black shading) or conditions in which overall Shh levels are increased (red shading). In Msx2-cre; Fgfr2CKO mice, Shh
levels are increased its normal expression domain rather than by ectopic Shh expression. (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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suggest that growth factor signals might regulate the pattern or
magnitude of Shh expression in the hair follicle. RNA in situ
hybridization was performed on Msx2-cre; Fgfr2cKO skin to dis-
tinguish between these possibilities (Fig. 9B). In situ hybridization
studies revealed that the overall expression pattern of Shh was
unchanged in the absence of Fgfr2. A comparison of the number of
Shh-positive cells in wildtype, Msx2-cre; Fgfr2cKO, and Msx2-cre;
KrasG12D hair follicles revealed no signiﬁcant difference in their
numbers (P¼0.4187 and P¼0.4355) (Fig. 9C). To verify whether
loss of ectodermal Fgfr2 was sufﬁcient to block acute Shh down-
regulation ex vivo, Msx2-cre; Fgfr2cKO explants were treated with
FGF2 (Fig. 9D). There was a small but signiﬁcant response of Shh
transcription to FGF2 in the Msx2-cre; Fgfr2cKO skin, which
indicating the presence of some residual functional FGFR activity.
Thus, increased Shh mRNA levels in Msx2-cre; Fgfr2cKO skin arise
independently of ectopic Shh expression (Fig. 9E).Discussion
In this study, hair morphogenesis was used as a model to study
the developmental response to RAS gain-of-function . We found that
in addition to the induction of a growth factor-responsive pathways,
the KrasG12D allele also causes the downregulation of Shh. Down-
regulation of Shh appears to be a normal response to growth factor
signaling in the hair follicle as veriﬁed through in vitro studies and
genetic loss of FGFR2 signaling. The hair follicle is sensitive to gain-of-function RAS mutations. In humans, hair shape and growth changes
are prevalent in patients with germline HRAS, KRAS, BRAF, MEK1, or
MEK2 (Roberts et al., 2006). In the mouse, we ﬁnd that Kras gain-of-
function affects hair formation in multiple ways. KrasG12D alters hair
length, features of the hair shaft, and as described previously, hair
cycling (Mukhopadhyay et al., 2011). Altered proliferation in the
Msx2-cre; KrasG12D hair follicle may contribute to many of the
observed hair defects. Proliferation in the hair matrix is linked to
the growth rate of the hair shaft. In addition, changes in proliferation
are associated with altered appearance of the hair shaft including
effects on hair bends in mice (Weger and Schlake, 2005). which is
consistent with reduced hair growth and may further contribute to
reduced numbers of medullary column and bend formation. KrasG12D
may also have independent effects of the above characteristics as
phenotypic changes in length, bends and medulla can independently
affected in mouse genetic mutants (Sundberg, 1994; Schlake, 2007).
The use of an explant system facilitated the assessment of
various growth factor signals that are normally present during
hair follicle morphogenesis. The observation that several different
growth factors are capable of Shh repression implies the activity
of a common downstream signaling component. We also ﬁnd that
two parallel RAS downstream pathways, RAF/MAPK and PI-3-
kinase, participate in Shh repression; further supporting the
concept that a common component of growth factor signaling is
a key regulator of Shh. We propose that RAS normally functions in
the hair follicle as a mediator of FGFR2 activation to suppress Shh.
SHH plays a major role in hair follicle growth (Chiang et al., 1999;
Mill et al., 2003; St-Jacques et al., 1998), and thus, it seems
A. Mukhopadhyay et al. / Developmental Biology 373 (2013) 373–382 381feasible that hair growth defects in RAS gain-of-function muta-
tions may result in part from decreased SHH levels. RAS gain-of-
function affected additional signaling pathways in the hair follicle.
How these additional signals cooperate with the suppression of Shh
in the hair follicle and other organs in RAS/MAPK syndromes requires
further investigation. Much of the knowledge on Shh transcrip-
tional regulation has focused on the complex cis-regulatory
elements regulating its restrictive pattern during organogenesis
(Amano et al., 2009; Epstein et al., 1999). However, little is known
regarding the mechanisms that control its level of expression. In
this study, we identify a rapid transcriptional response of the Shh
promoter in response to RAS activation and inhibition. The half-
life of Shh mRNA has not been previously reported. We ﬁnd that
unlike developmental signaling molecules, e.g., fgf8 (Dubrulle and
Pourquie´, 2004), Shh mRNA has a very short half-life . The 30
untranslated region of Shh is AU-rich like many short-lived
mRNAs but lacks classic AU-rich elements (Hau et al., 2007;
Zubiaga et al., 1995). The short half-life of Shh mRNA allows for
highly regulated patterns of Shh expression in developing organs,
where cells transiently occupy signaling centers. The short half-
life of Shh places signiﬁcant reliance on transcriptional mechan-
isms to achieve high steady state levels of Shh mRNA. We ﬁnd
evidence that regulation of Shh by FGF and RAS signaling play
important role in regulating the amplitude of Shh expression but
appears to be distinct from regulatory mechanisms that regulate
Shh pattern (cf. Fig. 9E). Increased expression of morphogens by
expansion of the expression domain often have deleterious effects
on the morphogenesis of an organ (Oro et al., 1997). Modulation
of morphogen level or sensitivity without disturbing pattern is a
possible mechanism for increasing organ growth and size without
affecting its shape. The observations from the hair follicle may not
be readily generalized to other organs. For example, in the limb
bud, FGFR2 signaling plays both a role in the initiation and
maintenance of normal domains of Shh expression (Lewandoski
et al., 2000) and a second role in preventing ectopic Shh expres-
sion in the anterior limb bud (Mao et al., 2009; Zhang et al., 2009).
It is also possible that FGFR2 function changes during the
dynamic period of the hair cycle, and thus we cannot rule out a
later function of FGF signaling in the regulation of Shh pattern
during other stages of hair growth. The variation in hair follicle
organ size at different body sites may well depend on the scalability
of Shh expression via FGF modulation. The above studies reveal that
hair formation, shape and growth are highly sensitive to RAS/MAPK
signals and serve as an even more sensitive measure than traditional
biochemical markers of RAS/MAPK activation. Further studies of hair
response to RAS/MAPK gain and loss-of-function may ﬁnd useful
application in the clinic not only in the evaluation of congenital
syndromes but also as a biomarker in cancer or response to RAS/
MAPK inhibition in cancer therapy.Acknowledgments
We are grateful to the following: T. Jacks (LSL-KrasG12D),
D. Ornitz (Fgfr2ﬂ/ﬂ), and G. Martin and R. Maxson (Msx2-cre), the
UCSD BIOGEM Microarray Core (microarray hybridization and
scanning), C. Jamora and members of the laboratory for reagents,
technical assistance and discussion. This work was supported by
the NIH/NIAMS to B.Y. (AR056667), CIRM to B.Y. (RN2-00908),
NIH/Ruth Kirschstein NRSA to J.B. (HL07491).Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2012.10.024.References
Amano, T., Sagai, T., Tanabe, H., Mizushina, Y., Nakazawa, H., Shiroishi, T., 2009.
Chromosomal dynamics at the Shh locus: limb bud-speciﬁc differential
regulation of competence and active transcription. Dev. Cell 16, 47–57.
Aoki, Y., Niihori, T., Kawame, H., Kurosawa, K., Ohashi, H., Tanaka, Y., Filocamo, M.,
Kato, K., Suzuki, Y., Kure, S., Matsubara, Y., 2005. Germline mutations in HRAS
proto-oncogene cause Costello syndrome. Nat. Genet. 37, 1038–1040.
Axelrad, M.E., Schwartz, D.D., Fehlis, J.E., Hopkins, E., Stabley, D.L., Sol-Church, K.,
Gripp, K.W., 2009. Longitudinal course of cognitive, adaptive, and behavioral
characteristics in Costello syndrome. Am. J. Med. Genet. A 149A, 2666–2672.
Bertola, D.R., Pereira, A.C., Brasil, A.S., Albano, L.M., Kim, C.A., Krieger, J.E., 2007.
Further evidence of genetic heterogeneity in Costello syndrome: involvement
of the KRAS gene. J. Hum. Genet. 52, 521–526.
Bollag, G., Hirth, P., Tsai, J., Zhang, J., Ibrahim, P.N., Cho, H., Spevak, W., Zhang, C.,
Zhang, Y., Habets, G., Burton, E.A., Wong, B., Tsang, G., West, B.L., Powell, B.,
Shellooe, R., Marimuthu, A., Nguyen, H., Zhang, K.Y.J., Artis, D.R., Schlessinger,
J., Su, F., Higgins, B., Iyer, R., D’Andrea, K., Koehler, A., Stumm, M., Lin, P.S., Lee,
R.J., Grippo, J., Puzanov, I., Kim, K.B., Ribas, A., McArthur, G.A., Sosman, J.A.,
Chapman, P.B., Flaherty, K.T., Xu, X., Nathanson, K.L., Nolop, K., 2010. Clinical
efﬁcacy of a RAF inhibitor needs broad target blockade in BRAF-mutant
melanoma. Nature 467, 596–599.
Brancaccio, A., Minichiello, A., Grachtchouk, M., Antonini, D., Sheng, H., Parlato, R.,
Dathan, N., Dlugosz, A.A., Missero, C., 2004. Requirement of the forkhead gene
Foxe1, a target of Sonic Hedgehog signaling, in hair follicle morphogenesis.
Hum. Mol. Genet. 13, 2595–2606.
Chiang, C., Swan, R.Z., Grachtchouk, M., Bolinger, M., Litingtung, Y., Robertson, E.K.,
Cooper, M.K., Gafﬁeld, W., Westphal, H., Beachy, P.A., Dlugosz, A.A., 1999.
Essential role for Sonic Hedgehog during hair follicle morphogenesis. Dev. Biol.
205, 1–9.
Corson, L.B., Yamanaka, Y., Lai, K.M., Rossant, J., 2003. Spatial and temporal
patterns of ERK signaling during mouse embryogenesis. Development 130,
4527–4537.
Courtois-Cox, S., Genther Williams, S.M., Reczek, E.E., Johnson, B.W., McGillicuddy,
L.T., Johannessen, C.M., Hollstein, P.E., MacCollin, M., Cichowski, K., 2006.
A negative feedback signaling network underlies oncogene-induced senes-
cence. Cancer Cell 10, 459–472.
Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A., Leder, P., 1996. Fibroblast growth
factor receptor 3 is a negative regulator of bone growth. Cell 84, 911–921.
Downward, J., 2003. Targeting RAS signaling pathways in cancer therapy. Nat. Rev.
3, 11–22.
Dubrulle, J., Pourquie´, O., 2004. Fgf8 mRNA decay establishes a gradient that
couples axial elongation to patterning in the vertebrate embryo. Nature 427,
419–422.
Epstein, D.J., McMahon, A.P., Joyner, A.L., 1999. Regionalization of Sonic Hedgehog
transcription along the anteroposterior axis of the mouse central nervous
system is regulated by Hnf3-dependent and -independent mechanisms.
Development 126, 281–292.
Etchevers, H.C., Vincent, C., Le Douarin, N.M., Couly, G.F., 2001. The cephalic neural
crest provides pericytes and smooth muscle cells to all blood vessels of the
face and forebrain. Development 128, 1059–1068.
Favata, M.F., Horiuchi, K.Y., Manos, E.J., Daulerio, A.J., Stradley, D.A., Feeser, W.S.,
Van Dyk, D.E., Pitts, W.J., Earl, R.A., Hobbs, F., Copeland, R.A., Magolda, R.L.,
Scherle, P.A., Trzaskos, J.M., 1998. Identiﬁcation of a novel inhibitor of
mitogen-activated protein kinase. J. Biol. Chem. 273, 18623–18632.
Greco, V., Chen, T., Rendl, M., Schober, M., Pasolli, H.A., Stokes, N., Dela Cruz-
Racelis, J., Fuchs, E., 2009. A two-step mechanism for stem cell activation
during hair regeneration. Cell Stem Cell 4, 155–169.
Gripp, K.W., Hopkins, E., Doyle, D., Dobyns, W.B., 2010. High incidence of
progressive postnatal cerebellar enlargement in Costello syndrome: brain
overgrowth associated with HRAS mutations as the likely cause of structural
brain and spinal cord abnormalities. Am. J. Med. Genet. A 152A, 1161–1168.
Grose, R., Fantl, V., Werner, S., Chioni, A.-M., Jarosz, M., Rudling, R., Cross, B., Hart,
I.R., Dickson, C., 2007. The role of ﬁbroblast growth factor receptor 2b in skin
homeostasis and cancer development. EMBO J. 26, 1268–1278.
Hau, H.H., Walsh, R.J., Ogilvie, R.L., Williams, D.A., Reilly, C.S., Bohjanen, P.R., 2007.
Tristetraprolin recruits functional mRNA decay complexes to are sequences.
J. Cell. Biochem. 100, 1477–1492.
Kawakami, Y., Rodriguez-Leon, J., Koth, C.M., Buscher, D., Itoh, T., Raya, A., Ng, J.K.,
Esteban, C.R., Takahashi, S., Henrique, D., Schwarz, M.F., Asahara, H., Izpisua
Belmonte, J.C., 2003. MKP3 mediates the cellular response to FGF8 signaling in
the vertebrate limb. Nat. Cell Biol. 5, 513–519.
Lackey, K., Cory, M., Davis, R., Frye, S.V., Harris, P.A., Hunter, R.N., Jung, D.K.,
McDonald, O.B., McNutt, R.W., Peel, M.R., Rutkowske, R.D., Veal, J.M., Wood,
E.R., 2000. The discovery of potent cRaf1 kinase inhibitors. Bioorg. Med. Chem.
Lett. 10, 223–226.
Lewandoski, M., Sun, X., Martin, G.R., 2000. Fgf8 signaling from the AER is essential
for normal limb development. Nat. Genet. 26, 460–463.
Lewis, P.M., Dunn, M.P., McMahon, J.A., Logan, M., Martin, J.F., St-Jacques, B.,
McMahon, A.P., 2001. Cholesterol modiﬁcation of Sonic Hedgehog is required
for long-range signaling activity and effective modulation of signaling by Ptc1.
Cell 105, 599–612.
Lin, A.E., Alexander, M.E., Colan, S.D., Kerr, B., Rauen, K.A., Noonan, J., Baffa, J.,
Hopkins, E., Sol-Church, K., Limongelli, G., Digilio, M.C., Marino, B., Innes, A.M.,
Aoki, Y., Silberbach, M., Delrue, M.-A., White, S.M., Hamilton, R.M., O’Connor,
W., Grossfeld, P.D., Smoot, L.B., Padera, R.F., Gripp, K.W., 2011. Clinical,
A. Mukhopadhyay et al. / Developmental Biology 373 (2013) 373–382382pathological, and molecular analyses of cardiovascular abnormalities in
Costello syndrome: A Ras/MAPK pathway syndrome. Amer. J. Med. Genet.
Part A 155A (3), 486–507.
Malumbres, M., Barbacid, M., 2003. RAS oncogenes: the ﬁrst 30 years. Nat. Rev.
Cancer 3, 459–465.
Mao, J., McGlinn, E., Huang, P., Tabin, C.J., McMahon, A.P., 2009. Fgf-dependent
Etv4/5 activity is required for posterior restriction of Sonic Hedgehog and
promoting outgrowth of the vertebrate limb. Dev. Cell 16, 600–606.
Marshall, C.J., 1995. Speciﬁcity of receptor tyrosine kinase signaling: transient
versus sustained extracellular signal-regulated kinase activation. Cell 80,
179–185.
Meijering, E., Jacob, M., Sarria, J.C., Steiner, P., Hirling, H., Unser, M., 2004. Design
and validation of a tool for neurite tracing and analysis in ﬂuorescence
microscopy images. Cytometry A 58, 167–176.
Mill, P., Mo, R., Fu, H., Grachtchouk, M., Kim, P.C.W., Dlugosz, A.A., Hui, C.-C., 2003.
Sonic Hedgehog-dependent activation of Gli2 is essential for embryonic hair
follicle development. Genes Dev. 17, 282–294.
Mukhopadhyay, A., Krishnaswami, S.R., Yu, B.D.Y., 2011. Activated Kras alters
epidermal homeostasis of mouse skin, resulting in redundant skin and
defective hair cycling. J. Invest. Dermatol. 131, 311–319.
Murphy, L.O., Smith, S., Chen, R.H., Fingar, D.C., Blenis, J., 2002. Molecular
interpretation of ERK signal duration by immediate early gene products. Nat.
Cell Biol. 4, 556–564.
Mustonen, T., Pispa, J., Mikkola, M.L., Pummila, M., Kangas, A.T., Pakkasjarvi, L.,
Jaatinen, R., Thesleff, I., 2003. Stimulation of ectodermal organ development by
Ectodysplasin-A1. Dev. Biol. 259, 123–136.
Noonan, J.A., 2006. Noonan syndrome and related disorders: alterations in growth
and puberty. Rev. Endoc. Metab. Disord. 7, 251–255.
Oro, A.E., Higgins, K.M., Hu, Z., Bonifas, J.M., Epstein Jr., E.H., Scott, M.P., 1997. Basal
cell carcinomas in mice overexpressing Sonic Hedgehog. Science 276,
817–821.
Pan, Y., Lin, M.H., Tian, X., Cheng, H.T., Gridley, T., Shen, J., Kopan, R., 2004. Gamma-
secretase functions through Notch signaling to maintain skin appendages but
is not required for their patterning or initial morphogenesis. Dev. Cell 7,
731–743.
Rauen, K.A., Schoyer, L., McCormick, F., Lin, A.E., Allanson, J.E., Stevenson, D.A.,
Gripp, K.W., Neri, G., Carey, J.C., Legius, E., Tartaglia, M., Schubbert, S., Roberts,
A.E., Gelb, B.D., Shannon, K., Gutmann, D.H., McMahon, M., Guerra, C., Fagin,
J.A., Yu, B., Aoki, Y., Neel, B.G., Balmain, A., Drake, R.R., Nolan, G.P., Zenker, M.,
Bollag, G., Sebolt-Leopold, J., Gibbs, J.B., Silva, A.J., Patton, E.E., Viskochil, D.H.,
Kieran, M.W., Korf, B.R., Hagerman, R.J., Packer, R.J., Melese, T., 2010. Proceed-
ings from the 2009 genetic syndromes of the Ras/MAPK pathway: from
bedside to bench and back. Am. J. Med. Genet. A 152A, 4–24.
Rendl, M., Lewis, L., Fuchs, E., 2005. Molecular dissection of mesenchymal-
epithelial interactions in the hair follicle. PLoS Biol. 3 e331-e331.
Reuther, G.W., Der, C.J., 2000. The Ras branch of small GTPases: Ras family
members don’t fall far from the tree. Curr. Opin. Cell Biol. 12, 157–165.
Roberts, A., Allanson, J., Jadico, S.K., Kavamura, M.I., Noonan, J., Opitz, J.M., Young,
T., Neri, G., 2006. The cardiofaciocutaneous syndrome. J. Med. Genet. 43,
833–842.
Rodriguez-Viciana, P., Tetsu, O., Oda, K., Okada, J., Rauen, K., McCormick, F., 2005.
Cancer targets in the Ras pathway. Cold Spring Harbor Symp. Quant. Biol. 70,
461–467.
Rodriguez-Viciana, P., Tetsu, O., Tidyman, W.E., Estep, A.L., Conger, B.A., Cruz, M.S.,
McCormick, F., Rauen, K.A., 2006. Germline mutations in genes within the
MAPK pathway cause cardio-facio-cutaneous syndrome. Science 311,
1287–1290.
Rodriguez-Viciana, P., Warne, P.H., Khwaja, A., Marte, B.M., Pappin, D., Das, P.,
Waterﬁeld, M.D., Ridley, A., Downward, J., 1997. Role of phosphoinositide
3-OH kinase in cell transformation and control of the actin cytoskeleton by
Ras. Cell 89, 457–467.
Rosenquist, T.A., Martin, G.R., 1996. Fibroblast growth factor signaling in the hair
growth cycle: expression of the ﬁbroblast growth factor receptor and ligand
genes in the murine hair follicle. Dev. Dyn. 205, 379–386.
Schlake, T., 2007. Determination of hair structure and shape. Semin. Cell Dev. Biol.
18, 267–273.
Schneider, M.R., Schmidt-Ullrich, R., Paus, R., 2009. The hair follicle as a dynamic
miniorgan. Curr. Biol. 19, R132–R142.Schubbert, S., Zenker, M., Rowe, S.L., Boll, S., Klein, C., Bollag, G., van der Burgt, I.,
Musante, L., Kalscheuer, V., Wehner, L.E., Nguyen, H., West, B., Zhang, K.Y.,
Sistermans, E., Rauch, A., Niemeyer, C.M., Shannon, K., Kratz, C.P., 2006.
Germline KRAS mutations cause Noonan syndrome. Nat. Genet. 38, 331–336.
Schweitzer, R., Shilo, B.Z., 1997. A thousand and one roles for the Drosophila EGF
receptor. Trends Genet. 13, 191–196.
Siegel, D.H., Mann, J.A., Krol, A.L., Rauen, K.A., 2012. Dermatological phenotype in
Costello syndrome: consequences of Ras dysregulation in development. Br. J.
Dermatol. 166, 601–607.
Siegel, D.H., McKenzie, J., Frieden, I.J., Rauen, K.A., 2011. Dermatological ﬁndings in
61 mutation-positive individuals with cardiofaciocutaneous syndrome. Br. J.
Dermatol. 164, 521–529.
St-Jacques, B., Dassule, H.R., Karavanova, I., Botchkarev, V.A., Li, J., Danielian, P.S.,
McMahon, J.A., Lewis, P.M., Paus, R., McMahon, A.P., 1998. Sonic Hedgehog
signaling is essential for hair development. Curr. Biol. 8, 1058–1068.
Sun, X., Lewandoski, M., Meyers, E.N., Liu, Y.H., Maxson, R.E., Martin, G.R., 2000.
Conditional inactivation of Fgf4 reveals complexity of signaling during limb
bud development. Nat. Genet. 25, 83–86.
Sundberg, J., 1994. Handbook of Mouse Mutations with Skin and Hair Abnormal-
ities: Animal Models and Biomedical Tools. CRC Press, Boca Raton.
Tabata, T., Kornberg, T.B., 1994. Hedgehog is a signaling protein with a key role in
patterning Drosophila imaginal discs. Cell 76, 89–102.
Tidyman, W.E., Rauen, K.A., 2009. The RASopathies: developmental syndromes of
Ras/MAPK pathway dysregulation. Curr. Opin. Genet. Dev. 19, 230–236.
Tuveson, D.A., Shaw, A.T., Willis, N.A., Silver, D.P., Jackson, E.L., Chang, S., Mercer,
K.L., Grochow, R., Hock, H., Crowley, D., Hingorani, S.R., Zaks, T., King, C.,
Jacobetz, M.A., Wang, L., Bronson, R.T., Orkin, S.H., DePinho, R.A., Jacks, T.,
2004. Endogenous oncogenic K-ras(G12D) stimulates proliferation and wide-
spread neoplastic and developmental defects. Cancer Cell 5, 375–387.
Verheyden, J.M., Lewandoski, M., Deng, C., Harfe, B.D., Sun, X., 2005. Conditional
inactivation of Fgfr1 in mouse deﬁnes its role in limb bud establishment,
outgrowth and digit patterning. Development 132, 4235–4245.
Vlahos, C.J., Matter, W.F., Hui, K.Y., Brown, R.F., 1994. A speciﬁc inhibitor of
phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzo-
pyran-4-one (LY294002). J. Biol. Chem. 269, 5241–5248.
Weger, N., Schlake, T., 2005. Igf-I signaling controls the hair growth cycle and the
differentiation of hair shafts. J. Invest. Dermatol. 125, 873–882.
Weinstein, M., Xu, X., Ohyama, K., Deng, C.X., 1998. FGFR-3 and FGFR-4 function
cooperatively to direct alveogenesis in the murine lung. Development 125,
3615–3623.
Yang, J., Meyer, M., Mu¨ller, A.-K., Bo¨hm, F., Grose, R., Dauwalder, T., Verrey, F., Kopf,
M., Partanen, J., Bloch, W., Ornitz, D.M., Werner, S., 2010. Fibroblast growth
factor receptors 1 and 2 in keratinocytes control the epidermal barrier and
cutaneous homeostasis. J. Cell. Biol. 188, 935–952.
Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., Ornitz, D.M., 1991. Cell surface,
heparin-like molecules are required for binding of basic ﬁbroblast growth
factor to its high afﬁnity receptor. Cell 64, 841–848.
Yekutieli, D., Benjamini, Y., 2001. The control of the false discovery rate in multiple
testing under dependency. Ann. Stat. 29, 1165–1188.
Yu, K., Ornitz, D.M., 2008. FGF signaling regulates mesenchymal differentiation
and skeletal patterning along the limb bud proximodistal axis. Development
135, 483–491.
Yu, K., Xu, J., Liu, Z., Sosic, D., Shao, J., Olson, E.N., Towler, D.A., Ornitz, D.M., 2003.
Conditional inactivation of FGF receptor 2 reveals an essential role for FGF
signaling in the regulation of osteoblast function and bone growth. Develop-
ment 130, 3063–3074.
Zhang, Z., Verheyden, J.M., Hassell, J.A., Sun, X., 2009. FGF-regulated Etv genes are
essential for repressing Shh expression in mouse limb buds. Dev. Cell 16,
607–613.
Zenker, M., Lehmann, K., Schulz, A.L., Barth, H., Hansmann, D., Koenig, R.,
Korinthenberg, R., Kreiss-Nachtsheim, M., Meinecke, P., Morlot, S., Mundlos,
S., Quante, A.S., Raskin, S., Schnabel, D., Wehner, L.E., Kratz, C.P., Horn, D.,
Kutsche, K., 2007. Expansion of the genotypic and phenotypic spectrum in
patients with KRAS germline mutations. J. Med. Genet. 44, 131–135.
Zubiaga, A.M., Belasco, J.G., Greenberg, M.E., 1995. The nonamer UUAUUUAUU is
the key AU-rich sequence motif that mediates mRNA degradation. Mol. Cell.
Biol. 15, 2219–2230.
